Silence Therapeutics Statistics
Total Valuation
SLN has a market cap or net worth of $301.35 million. The enterprise value is $216.40 million.
Important Dates
The last earnings date was Thursday, March 5, 2026, before market open.
| Earnings Date | Mar 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SLN has 47.23 million shares outstanding. The number of shares has increased by 2.12% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 47.23M |
| Shares Change (YoY) | +2.12% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 34.66% |
| Owned by Institutions (%) | 27.09% |
| Float | 24.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 539.09 |
| Forward PS | n/a |
| PB Ratio | 4.84 |
| P/TBV Ratio | 5.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 387.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.72, with a Debt / Equity ratio of 0.00.
| Current Ratio | 8.72 |
| Quick Ratio | 8.06 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -90.27% and return on invested capital (ROIC) is -52.32%.
| Return on Equity (ROE) | -90.27% |
| Return on Assets (ROA) | -30.79% |
| Return on Invested Capital (ROIC) | -52.32% |
| Return on Capital Employed (ROCE) | -69.84% |
| Weighted Average Cost of Capital (WACC) | 11.68% |
| Revenue Per Employee | $6,352 |
| Profits Per Employee | -$1.01M |
| Employee Count | 88 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SLN has paid $11,000 in taxes.
| Income Tax | 11,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +67.90% in the last 52 weeks. The beta is 1.35, so SLN's price volatility has been higher than the market average.
| Beta (5Y) | 1.35 |
| 52-Week Price Change | +67.90% |
| 50-Day Moving Average | 5.50 |
| 200-Day Moving Average | 5.82 |
| Relative Strength Index (RSI) | 55.44 |
| Average Volume (20 Days) | 283,118 |
Short Selling Information
The latest short interest is 1.55 million, so 3.29% of the outstanding shares have been sold short.
| Short Interest | 1.55M |
| Short Previous Month | 1.55M |
| Short % of Shares Out | 3.29% |
| Short % of Float | 6.23% |
| Short Ratio (days to cover) | 8.92 |
Income Statement
In the last 12 months, SLN had revenue of $559,000 and -$88.61 million in losses. Loss per share was -$1.88.
| Revenue | 559,000 |
| Gross Profit | 344,000 |
| Operating Income | -82.29M |
| Pretax Income | -88.60M |
| Net Income | -88.61M |
| EBITDA | -81.74M |
| EBIT | -82.29M |
| Loss Per Share | -$1.88 |
Full Income StatementBalance Sheet
The company has $85.11 million in cash and $160,000 in debt, with a net cash position of $84.95 million or $1.80 per share.
| Cash & Cash Equivalents | 85.11M |
| Total Debt | 160,000 |
| Net Cash | 84.95M |
| Net Cash Per Share | $1.80 |
| Equity (Book Value) | 62.30M |
| Book Value Per Share | 1.32 |
| Working Capital | 105.05M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$62.27 million and capital expenditures -$55,000, giving a free cash flow of -$62.33 million.
| Operating Cash Flow | -62.27M |
| Capital Expenditures | -55,000 |
| Depreciation & Amortization | 555,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -62.33M |
| FCF Per Share | -$1.32 |
Full Cash Flow StatementMargins
| Gross Margin | 61.54% |
| Operating Margin | -14,720.93% |
| Pretax Margin | -15,849.91% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SLN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.12% |
| Shareholder Yield | -2.12% |
| Earnings Yield | -29.40% |
| FCF Yield | -20.68% |
Analyst Forecast
The average price target for SLN is $42.60, which is 567.71% higher than the current price. The consensus rating is "Buy".
| Price Target | $42.60 |
| Price Target Difference | 567.71% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SLN has an Altman Z-Score of -4.92 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.92 |
| Piotroski F-Score | 1 |
